26Jan/24
Positive Outcomes in Clinical Trial of Cord Blood-Derived CAR-NK Cell Therapy for B Cell Malignancies
In a recent study, researchers from the University of Texas MD Anderson Cancer Center in the United States reported favorable results from a Phase I/II clinical trial involving 37 patients with relapsedRead More…